Niederer Kraft Frey acted as counsel to Idorsia. The team was led by partner Philipp Haas (pictured right). Bär & Karrer acted as legal advisor to the Joint Bookrunners in this transaction. The team included
Tags :Idorsia
Idorsia, a Swiss biopharmaceutical company, completed a private placement with institutional investors of 11m new registered shares, corresponding to 8.4% of its currently issued share capital, issued out of its authorized share capital by way of
